We would love to hear your thoughts about our site and services, please take our survey here.
Bighero commends excellence where it is due. CK, I doth my feather cap to you
That’s sad you’ve made a loss but next year might turnaround
No tax to pay from your share portfolio though CK? Bighero has a huge tax bill because I’ve made so much money this year.
The U.K. government have changed from weekly testing to a ‘risk assessment approach’
You’re local hero thought this might have been missed. What does this do for the government contract. Are we reliant on DAM health now? It has gone from government, to Mologic, to FDA, to U.K. HUA and now DAM Health. Is this finally the arrow ODX need. Fire enough and surely one will hit the target?
Bighero is always investigating. A magnifying glass always with arms reach for forensic inspection.
The government have ditched twice weekly LFT recommendations.
The below is from the page updates of this here little link.
https://www.gov.uk/guidance/covid-19-coronavirus-restrictions-what-you-can-and-cannot-do#take-tests-if-you-do-not-have-symptoms-to-help-manage-your-risk
“ 17 November 2021
Guidance updated to reflect the move from recommending twice-weekly lateral flow testing to a risk-based approach.”
I expect the TWatcher collective to be all over this.
Bighero cares, Bighero made loads of money today. More than you can stuff in Santa’s sack.
Looks like King Alistair Smith has outdone Prince Colin King. Bighero weeps with tears of joy for joining the share I cannot name at the lows recently.
Bighero has been evaluating himself and has taken some time off for reflection. The result is that Bighero really is an excellent trader, makes more money than the vast majority on here and the fan club is still clamouring for information. A real local hero to the LSE board.
From the article:
“Its share price touched 275p this summer on news of the accreditation of its diagnostic test and progress with the AVA6000 therapy. The price has since drifted back down to something close to the level at which it started the year, around 110p at the time of writing, taking the company’s market cap back down to £275m. It’s a pattern indicative of the challenge smaller biotechs have in sustaining share momentum: key announcements are relatively few, and if positive tend to generate relatively short spikes.”
“ "Hello Captain, you mentioned recently your portfolio is doing well. What other shares are you in?"
nope. not me. I haven't said anything about my portfolio other than my ODX position.“
I think it’s probably Bighero you refer to. An excellent looking YTD increase and the trades have generally been exceptional.
DAM also have to pay for many other variable costs after they have purchased the LFT. They will be making a nice profit but they don’t just buy the test and then everything is free to them. These silly sausages believing they are paying £15 per test are eating pie from the clouds in the sky.
Simple as that Steve has bad grammar
Total rubbish
Bighero would be a delicious ice cream.
Bighero would be an even better share. Better than ODX anyway.
It’s time to leave this share for the share I cannot name. The decent traders like Bighero have made a lot of money from ODX with its consistent 10% rise and falls. I have said that all along and I have been proved right yet again.
I thank ODX for the money but now it’s time to move on to Covid diagnostics pastures (nearly) new. We have all done very well here so let’s do really well elsewhere in a place we can’t talk about. It’s an exquisite test though.
Sounds like a great combo to Bighero. Positive LFT, tell the Doctor as you know you’re ‘at risk’, pop some pills. Wonderful!
Of course it would be a Visitect LFT.